Pluri (PLUR) Gross Profit (2011 - 2025)
Pluri (PLUR) posted quarterly Gross Profit of $86000.0 for Q4 2025, down 22.52% year-over-year from $111000.0 in Q4 2024, and down 25.22% quarter-over-quarter from $115000.0 in Q3 2025.
Pluri (PLUR) Gross Profit (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Gross Profit for 12 consecutive years, with $86000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Gross Profit fell 22.52% year-over-year to $86000.0; the TTM figure through Dec 2025 stood at $544000.0 (up 14.77% YoY), while the FY2025 annual figure was $654000.0, up 103.11% from the prior year.
- Gross Profit eased to $86000.0 in Q4 2025 per PLUR's latest filing, from $115000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $207000.0 in Q2 2025 and bottomed at $54000.0 in Q3 2023.
- Historically, Gross Profit has averaged $117700.0 across 3 years, with a median of $108000.0 in 2023.
- Annual changes were most pronounced in 2024 — Gross Profit surged 270.37% — and 2025, when it tumbled 42.5%.
- Pluri's Gross Profit stood at $105000.0 in 2023, then increased by 5.71% to $111000.0 in 2024, then decreased by 22.52% to $86000.0 in 2025.
- Business Quant data shows PLUR's Gross Profit at $86000.0 in Q4 2025, $115000.0 in Q3 2025, and $207000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 86,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Dec 31, 2024 | 111,000.00 |
| Dec 31, 2024 | 111,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Mar 31, 2024 | 71,000.00 |
| Mar 31, 2024 | 71,000.00 |
| Dec 31, 2023 | 105,000.00 |
| Dec 31, 2023 | 105,000.00 |
| Sep 30, 2023 | 54,000.00 |
| Sep 30, 2023 | 54,000.00 |